Total Payments
$2,050
2024 Payments
$240.64
Companies
12
Transactions
88
Medicare Patients
491
Medicare Billing
$127,758
Payment Breakdown by Category
Food & Beverage$1,995 (97.3%)
Education$54.54 (2.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,995 | 84 | 97.3% |
| Education | $54.54 | 4 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,036 | 59 | $0 (2020) |
| Alkermes, Inc. | $340.36 | 7 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $162.06 | 8 | $0 (2019) |
| ITI, Inc. | $142.37 | 2 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $140.65 | 3 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $96.17 | 1 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $43.74 | 3 | $0 (2019) |
| LivaNova USA, Inc. | $27.16 | 1 | $0 (2024) |
| Shire North American Group Inc | $20.49 | 1 | $0 (2019) |
| Lundbeck LLC | $15.86 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $240.64 | 3 | Teva Pharmaceuticals USA, Inc. ($117.31) |
| 2023 | $251.14 | 3 | Alkermes, Inc. ($251.14) |
| 2021 | $142.37 | 2 | ITI, Inc. ($142.37) |
| 2020 | $107.42 | 6 | Otsuka America Pharmaceutical, Inc. ($64.42) |
| 2019 | $653.27 | 30 | Otsuka America Pharmaceutical, Inc. ($407.33) |
| 2018 | $469.13 | 25 | Otsuka America Pharmaceutical, Inc. ($408.02) |
| 2017 | $185.77 | 19 | Otsuka America Pharmaceutical, Inc. ($156.11) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: Neurology | ||||||
| 10/10/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $117.31 | General |
| Category: Neurology | ||||||
| 09/26/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $96.17 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/21/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $113.68 | General |
| Category: CNS | ||||||
| 05/24/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $114.53 | General |
| Category: CNS | ||||||
| 03/24/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: CNS | ||||||
| 08/13/2021 | ITI, Inc. | CAPLYTA (Drug) | Education | In-kind items and services | $46.91 | General |
| Category: PSYCHIATRY | ||||||
| 01/19/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $95.46 | General |
| Category: PSYCHIATRY | ||||||
| 03/13/2020 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: CNS | ||||||
| 03/04/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: PSYCHIATRY | ||||||
| 03/02/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: PSYCHIATRY | ||||||
| 02/25/2020 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: CNS | ||||||
| 01/25/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: PSYCHIATRY | ||||||
| 01/09/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $4.47 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $98.94 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: PSYCHIATRY | ||||||
| 09/13/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: CNS | ||||||
| 09/04/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: PSYCHIATRY | ||||||
| 08/23/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Central Nervous System (CNS) | ||||||
| 08/15/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 94 | 327 | $90,614 | $19,085 |
| 2022 | 7 | 136 | 589 | $183,346 | $34,711 |
| 2021 | 5 | 137 | 579 | $157,825 | $34,812 |
| 2020 | 6 | 124 | 633 | $162,622 | $39,151 |
Total Patients
491
Total Services
2,128
Medicare Billing
$127,758
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90870 | Therapy using electrical currents | Facility | 2023 | 14 | 109 | $38,150 | $8,974 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 106 | $10,600 | $5,478 | 51.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 42 | 88 | $27,104 | $3,191 | 11.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 24 | 24 | $14,760 | $1,442 | 9.8% |
| 90870 | Therapy using electrical currents | Facility | 2022 | 15 | 152 | $53,200 | $12,733 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 15 | 145 | $14,500 | $7,721 | 53.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 119 | $45,640 | $6,785 | 14.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 28 | 116 | $32,828 | $3,463 | 10.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 19 | $11,438 | $1,531 | 13.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 22 | 24 | $13,560 | $1,320 | 9.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 14 | 14 | $12,180 | $1,157 | 9.5% |
| 90870 | Shock treatment and monitoring | Facility | 2021 | 19 | 179 | $62,650 | $15,431 | 24.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 19 | 166 | $16,600 | $8,999 | 54.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 33 | 75 | $25,880 | $4,377 | 16.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 33 | 119 | $31,535 | $3,654 | 11.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 33 | 40 | $21,160 | $2,351 | 11.1% |
| 90870 | Shock treatment and monitoring | Facility | 2020 | 25 | 234 | $81,855 | $20,659 | 25.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 23 | 181 | $18,100 | $7,552 | 41.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 22 | 107 | $31,679 | $6,373 | 20.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 24 | 75 | $18,750 | $2,443 | 13.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 16 | 22 | $10,978 | $1,332 | 12.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 14 | 14 | $1,260 | $791.76 | 62.8% |
About Dr. Christopher Reyburn, M.D
Dr. Christopher Reyburn, M.D is a Psychiatry healthcare provider based in Laramie, Wyoming. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1770624017.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Reyburn, M.D has received a total of $2,050 in payments from pharmaceutical and medical device companies, with $240.64 received in 2024. These payments were reported across 88 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,995).
As a Medicare-enrolled provider, Reyburn has provided services to 491 Medicare beneficiaries, totaling 2,128 services with total Medicare billing of $127,758. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Laramie, WY
- Active Since 02/09/2007
- Last Updated 07/09/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1770624017
Products in Payments
- ABILIFY MAINTENA (Drug) $861.30
- ARISTADA (Drug) $205.17
- REXULTI (Drug) $190.44
- LATUDA (Drug) $162.06
- CAPLYTA (Drug) $142.37
- UZEDY (Drug) $117.31
- LYBALVI (Drug) $113.68
- FANAPT (Drug) $96.17
- INGREZZA (Drug) $43.74
- VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) $27.16
- AUSTEDO (Drug) $23.34
- Aristada 441 mg (Drug) $21.51
- VYVANSE (Drug) $20.49
- Trintellix (Drug) $13.56
- Evekeo (Drug) $11.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.